COLLIS STEVEN H 4

What Happened

• Steven H. Collis, a director of Elevance Health (ELV), reported a purchase of 3,000 ordinary shares on 2026-03-05. The transaction price was $289.84 per share for a total cost of $869,520. This was a purchase (P), which investors often view as a more informative signal than routine sales.

Key Details

• Transaction date: 2026-03-05
• Price per share: $289.84; Total value: $869,520
• Transaction type: P = open-market or private purchase (Form 4 uses code "P")
• Filing date / Accession: Form 4 filed 2026-03-06 (Accession 0001191508-26-000002) — filed promptly after the trade
• Shares owned after transaction: Not specified in the provided filing excerpt
• No footnotes provided in the supplied data (e.g., 10b5-1 plan, tax withholding)

Context

• This report reflects an outright purchase of shares (not an option exercise, award, or gift). Purchases by insiders can indicate confidence in the company but do not prove future performance; use alongside other research.